Multidisciplinary team discussion: the emerging gold standard for management of cardiopulmonary complications of connective tissue disease-Reference-Cited by-同舟云学术

Multidisciplinary team discussion: the emerging gold standard for management of cardiopulmonary complications of connective tissue disease

Published:2023-09-29 Issue:10 Volume:53 Page:1919-1924
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Internal Medicine Journal

Author:

Fairley Jessica L.¹²^ORCID,Ross Laura¹²,Burns Andrew¹³,Prior David¹³,Conron Matthew⁴,Rouse Hannah⁵,McDonald Julie⁴,MacIsaac Andrew³,La Gerche André¹⁶,Morrisroe Kathleen¹²,Ferdowsi Nava²,Quinlivan Alannah¹²,Brown Zoe¹²,Stevens Wendy²,Nikpour Mandana¹²

Affiliation:

1. Department of Medicine The University of Melbourne Melbourne Victoria Australia

2. Department of Rheumatology St. Vincent's Hospital Melbourne Melbourne Victoria Australia

3. Department of Cardiology St Vincent's Hospital Melbourne Melbourne Australia

4. Department of Respiratory Medicine St Vincent's Hospital Melbourne Melbourne Australia

5. Department of Radiology St Vincent's Hospital Melbourne Melbourne Victoria Australia

6. Baker Heart and Diabetes Institute Victoria Australia

Abstract

AbstractCardiopulmonary complications of connective tissue diseases (CTDs), particularly pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD), are major determinants of morbidity and mortality. Multidisciplinary meetings may improve diagnostic accuracy and optimise treatment. We review the literature regarding multidisciplinary meetings in CTD‐ILD and PAH and describe our tertiary centre experience of the role of the multidisciplinary meeting in managing CTD‐PAH.

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.16233

Reference50 articles.

1. Early Mortality in a Multinational Systemic Sclerosis Inception Cohort

2. Risk factors for early mortality in scleroderma patients: a report from the eular scleroderma trials and research group (EUSTAR) database;Carreira PE;Arthritis Rheum,2012

3. Mortality and its predominant causes in a large cohort of patients with biopsy-determined inflammatory myositis

4. Changes in causes of death in systemic sclerosis, 1972-2002

5. Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension